Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence

Oncogene

Volumn 18, Issue 40, 1999, Pages 5525-5534

  Wong, Ken S ^a   Li, You Jun ^a   Howard, Jeff ^b   Ben David, Yaacov ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Epo; Friend leukemia; Genetic instability; Immortalization; P53

Indexed keywords

PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL IMMORTALIZATION; CELL SURVIVAL; ERYTHROLEUKEMIA; FRIEND LEUKEMIA VIRUS; GENE LOSS; GENE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; TUMOR SUPPRESSOR GENE;

ANIMALS; ANIMALS, NEWBORN; BLOOD PROTEINS; CELL AGING; CELL DIVISION; DISEASE PROGRESSION; DNA-BINDING PROTEINS; ERYTHROID PROGENITOR CELLS; ERYTHROPOIETIN; FEMALE; FRIEND MURINE LEUKEMIA VIRUS; GENE DELETION; GENE EXPRESSION REGULATION, LEUKEMIC; GENES, P53; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MUTAGENESIS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEIN C-FLI-1; PROTO-ONCOGENE PROTEINS; RETROVIRIDAE INFECTIONS; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS;

ANIMALIA; FRIEND MURINE LEUKEMIA VIRUS; MURINAE; MURINE LEUKEMIA VIRUS; RNA VIRUSES;

EID: 0033619189     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202938     Document Type: Article

References (46)

1. Baker SJ, Preisinger AC, Jessup JM, Paraskeva C, Markowitz S, Willson JK, Hamilton S and Vogelstein B. (1990). Cancer Res., 50, 7717-7722.
2. Bartholomew C and Ihle JN, (1991). Mol. Cell Biol., 11, 1820-1828.
3. Ben-David Y, Bani MR, Chabot B, de Koven A and Bernstein A. (1992). Mol. Cell. Biol., 12, 4449-4455.
4. Ben-David Y and Bernstein A. (1991b), Cell, 66, 831-834.
5. Ben-David Y, Giddens EG, Letwin K and Bernstein A. (1991a). Genes Dev., 5, 908-918.
6. Blount PL, Meltzer SJ, Yin J, Huang Y and Krasna MJ. (1993). Proc. Natl. Acad. Sci. USA, 90, 3221-3225.
7. Bordereaux D, Fichelson S, Sola B, Tambourin PE and Gisselbrecht S. (1987). J. Virol., 61, 4043-4045.
8. Cheng J and Haas M. (1990). Mol. Cell Biol., 10, 5502-5509.
9. Chow V, Ben-David Y, Bernstein A, Benchimol S and Mowat G. (1987). J. Virol., 61, 2777-2781.
10. Donehower LA, Godley LA, Aldaz CM, Pyle R, Shi Y, Pinkel D, Gray J, Bradley A, Medina D and Varmus HE. (1995a). Genes Dev., 882.
11. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS and Bradley A. (1992). Nature, 356, 215-221.
12. Donehower LA, Harvey M, Vogel H, McArthur MJ, Montgomery Jr CA, Park SH, Thompson T. Ford RJ and Bradley A. (1995b). Mol. Carcinog., 14, 16-22.
13. Dreyfus F, Sola B, Fichelson S, Varlet P, Charon M, Tambourin P, Wendling F and Gisselbrecht S. (1990). Leukemia, 4, 590-594.
14. Dudenhoffer C, Rohaly G, Will K, Deppert W and Wiesmuller L. (1998). Mol. Cell Biol., 18, 5332-5342.
15. Fukasawa K, Wiener F, Vande Woude GF and Mai S. (1997), Oncogene, 15, 1295-1302.
16. Harvey M, McArthur MJ, Montgomery Jr CA, Bradley A and Donehower LA. (1993). FASEB J., 7, 938-943.
17. Hicks GG and Mowat M. (1988). J. Virol., 62, 4752-4755.
18. Howard JC, Berger L, Bani MR, Hawley R and Ben-David Y. (1996a). Oncogene, 12, 1405-1415.
19. Howard JC, Ung Y, Adachi D and Ben-David Y. (1996b). Cell Growth Differ., 7, 1651-1660.
20. Howard JC, Yousefi S, Cheong G, Bernstein A and Ben-David Y. (1993). Oncogene. 8, 2721-2729.
21. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT and Weinberg RA. (1994). Curr. Biol., 4, 1-7.
22. Jenkins JR, Rudge K and Currie GA. (1984). Nature, 312, 651-654.
23. Johnson P, Chung S and Benchimol S. (1993). Mol. Cell Biol., 13, 1456-1463.
24. Jonkers J and Berns A. (1996). Biochim. Biophys. Acta, 1287, 29-57.
25. Kabat D. (1990). Curr. Top. Microbiol. Immunol., 148, 1-42.
26. Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB. (1992). Proc. Natl. Acad Sci. USA. 89, 7491-7495.
27. Lavigueur A and Bernstein A. (1991). Oncogene, 6, 2197-2201.
28. Lavigueur A, Maltby V, Mock D, Rossant J, Pawson T and Bernstein A. (1989). Mol. Cell. Biol., 9, 3982-3991.
29. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T und Tlsty TD. (1992). Cell. 70, 923-935.
30. Lu SJ, Rowan S, Bani MR and Ben-David Y. (1994). Proc. Natl. Acad. Sci. USA, 91, 8398-8402.
31. McDonald J, Beru N and Goldwasser E. (1987). Mol. Cell. Biol., 7, 365-370.
32. Moreau-Gachelin F, Tavitian A and Tambourin P. (1988). Nature, 331, 277-280.
33. Mortensen RM, Conner DA, Chao S, Geisterfer-Lowrance AA and Seidman JG. (1992). Mol. Cell Biol., 12, 2391-2395.
34. Mucenski ML, Taylor BA, Ihle JN, Hartley JW, Morse HC3, Jenkins NA and Copeland NG. (1988). Mol. Cell Biol., 8, 301-308.
35. Okamoto A, Sameshima Y, Yokoyama S, Terashima Y, Sugimura T, Terada M and Yokota J. (1991). Cancer Res., 51, 5171-5176.
36. Purdie CA, Harrison DJ, Peter A, Dobbie L, White S, Howie SE, Salter DM, Bird CC, Wyllie AH and Hooper ML. (1994), Oncogene, 9, 603-609.
37. Ryan JJ, Danish R, Gottlieb C and Clarke M. (1993). Mol. Cell. Biol., 13, 711-719.
38. Saris CJ, Domen J and Berns A. (1991). EMBO J., 10, 655-664.
39. Selten G, Cuypers HT, Zijlstra M, Melief C and Berns A. (1984). EMBO J., 3, 3215-3222.
40. Shibuya T and Mak T. (1983). Proc. Natl. Acad. Sci. USA, 80, 3721-3725.
41. Silver J and Kozak C. (1986). J. Virol., 57, 526-533.
42. Tsai S, Bartelmez S, Sitnicka E and Collins S. (1994). Genes Dev. 8, 2831-2841.
43. Ushijima T, Makino H, Okonogi H, Hosoya Y, Sugimura T and Nagao M. (1995). Mol. Carcinog., 12, 23-30.
44. Williams AC, Miller JC, Collard TJ, Bracey TS, Cosulich S and Paraskeva C. (1995). Oncogene, 11, 141-149.
45. Yin Y, Tainsky MA, Bischoff FZ, Strong LC and Wahl GM. (1992). Cell, 70, 937-948.
46. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A and Oren M. (1991). Nature, 352, 345-347.